CA Patent

CA3231425A1 — Pharmaceutical composition of bempedoic acid

Assigned to Synthon BV · Expires 2023-03-16 · 3y expired

What this patent protects

The presented invention relates to pharmaceutical composition comprising Bempedoic acid and processes for preparation thereof.

USPTO Abstract

The presented invention relates to pharmaceutical composition comprising Bempedoic acid and processes for preparation thereof.

Drugs covered by this patent

fostamatinib-disodium (FOSTAMATINIB DISODIUM)

Patent Metadata

Patent number: CA3231425A1
Jurisdiction: CA
Classification: —
Expires: 2023-03-16
Drug substance claim: No
Drug product claim: No
Assignee: Synthon BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.